Blueprint Medicines Corporation (BPMC) SEC filings
BPMC SEC filings moved a median of +0.26% by the close. BPMC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the BPMC overview →
36 measured BPMC SEC filing events.
Where these BPMC SEC filings landedvs 31 measured BPMC SEC filing reactions
| Middle 50% of BPMC SEC filing reactions | -1.54% to +3.40% |
|---|---|
| Median reaction (to close) | +0.26% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 BPMC SEC filing events with a measured close landed between -1.54% and +3.40%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Blueprint Medicines Corp | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Blueprint Medicines Corp | SEC filing · Form EFFECT | — | — | |
| Form 8-K Blueprint Medicines Corp For: Jul 16 | SEC filing · Form 8-K | — | — | |
| Form POS AM Blueprint Medicines Corp | SEC filing · Form POS | — | — | |
| Form S-8 POS Blueprint Medicines Corp | SEC filing · Form S-8 | — | — | |
| Form 8-K Blueprint Medicines Corp For: Jun 18 | SEC filing · Form 8-K | -0.14% | -0.07% | |
| Form 8-K Blueprint Medicines Corp For: Jun 02 | SEC filing · Form 8-K | -0.10% | -0.16% | |
| Form 10-Q Blueprint Medicines Corp For: Mar 31 | SEC filing · Form 10-Q | +0.95% | +5.43% | |
| Form 8-K Blueprint Medicines Corp For: May 01 | SEC filing · Form 8-K | +0.80% | +8.90% | |
| Form ARS Blueprint Medicines Corp For: Dec 31 | SEC filing · Form ARS | -0.35% | +3.40% | |
| Form DEF 14A Blueprint Medicines Corp For: Jun 18 | SEC filing · Form DEF | -0.35% | +3.40% | |
| Form DEFA14A Blueprint Medicines Corp | SEC filing · Form DEFA14A | -0.35% | +3.40% | |
| Form 10-K Blueprint Medicines Corp For: Dec 31 | SEC filing · Form 10-K | -0.65% | -2.43% | |
| Form 8-K Blueprint Medicines Corp For: Feb 13 | SEC filing · Form 8-K | +0.76% | +0.20% | |
| Form S-8 Blueprint Medicines Corp | SEC filing · Form S-8 | -0.65% | -2.43% | |
| Form 8-K Blueprint Medicines Corp For: Jan 13 | SEC filing · Form 8-K | -0.64% | +7.18% | |
| Form 8-K Blueprint Medicines Corp For: Dec 13 | SEC filing · Form 8-K | -0.70% | -3.17% | |
| Form 10-Q Blueprint Medicines Corp For: Sep 30 | SEC filing · Form 10-Q | -1.60% | -1.93% | |
| Form 8-K Blueprint Medicines Corp For: Oct 30 | SEC filing · Form 8-K | +1.52% | -3.00% | |
| Form 10-Q Blueprint Medicines Corp For: Jun 30 | SEC filing · Form 10-Q | -0.21% | +0.35% | |
| Form 8-K Blueprint Medicines Corp For: Aug 01 | SEC filing · Form 8-K | +0.27% | -5.84% | |
| Form S-8 Blueprint Medicines Corp | SEC filing · Form S-8 | -1.01% | +1.73% | |
| Form 8-K Blueprint Medicines Corp For: Jun 12 | SEC filing · Form 8-K | -0.32% | -1.11% | |
| Form 8-K Blueprint Medicines Corp For: May 22 | SEC filing · Form 8-K | +0.71% | +0.06% | |
| Form 10-Q Blueprint Medicines Corp For: Mar 31 | SEC filing · Form 10-Q | -0.97% | -2.40% | |
| Form 8-K Blueprint Medicines Corp For: May 02 | SEC filing · Form 8-K | -0.88% | +3.00% | |
| Form 8-K Blueprint Medicines Corp For: Apr 25 | SEC filing · Form 8-K | -0.27% | +1.33% | |
| Form ARS Blueprint Medicines Corp For: Dec 31 | SEC filing · Form ARS | -1.25% | +0.26% | |
| Form DEF 14A Blueprint Medicines Corp For: Jun 12 | SEC filing · Form DEF | -1.25% | +0.26% | |
| Form 8-K Blueprint Medicines Corp For: Feb 22 | SEC filing · Form 8-K | +0.36% | -1.15% | |
| Form S-8 Blueprint Medicines Corp | SEC filing · Form S-8 | +1.71% | +2.55% | |
| Form 10-K Blueprint Medicines Corp For: Dec 31 | SEC filing · Form 10-K | +2.30% | -0.22% | |
| Form 8-K Blueprint Medicines Corp For: Feb 15 | SEC filing · Form 8-K | +7.83% | +12.72% | |
| Form 8-K Blueprint Medicines Corp For: Jan 08 | SEC filing · Form 8-K | -4.15% | +4.65% | |
| Form 10-Q Blueprint Medicines Corp For: Sep 30 | SEC filing · Form 10-Q | -2.16% | -4.64% | |
| Form 8-K Blueprint Medicines Corp For: Oct 26 | SEC filing · Form 8-K | +5.21% | +13.90% |
Keep exploring
More BPMC: earnings → · analyst actions → · BPMC overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SPRING BANK PHARMACEUTICALS (SBPH) | 404 | 0.00% | 37% |
| AKCEA THERAPEUTICS (AKCA) | 401 | 0.00% | 49% |
| EDGE THERAPEUTICS (EDGE) | 401 | -0.05% | 41% |
| Esperion Therapeutics, Inc. (ESPR) | 401 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.